NASDAQ:AZTA - Nasdaq - US1143401024 - Common Stock - Currency: USD
31.16
-0.95 (-2.96%)
The current stock price of AZTA is 31.16 USD. In the past month the price increased by 4.07%. In the past year, price decreased by -41.69%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 18.94 | 156.56B | ||
DHR | DANAHER CORP | 25.51 | 136.01B | ||
A | AGILENT TECHNOLOGIES INC | 21.11 | 32.38B | ||
IQV | IQVIA HOLDINGS INC | 14.22 | 27.79B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 29.53 | 24.83B | ||
WAT | WATERS CORP | 24.14 | 17.11B | ||
ILMN | ILLUMINA INC | 28.87 | 15.22B | ||
WST | WEST PHARMACEUTICAL SERVICES | 31.76 | 15.15B | ||
ICLR | ICON PLC | 10.46 | 11.41B | ||
RVTY | REVVITY INC | 18.92 | 10.99B | ||
TEM | TEMPUS AI INC | N/A | 10.56B | ||
QGEN | QIAGEN N.V. | 21.03 | 10.47B |
Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. The company is headquartered in Burlington, Massachusetts and currently employs 3,000 full-time employees. The firm provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The firm's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The firm's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The firm's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
AZENTA INC
200 Summit Drive, 6Th Floor
Burlington MASSACHUSETTS US
Employees: 3000
Phone: 19782622400
The current stock price of AZTA is 31.16 USD. The price decreased by -2.96% in the last trading session.
The exchange symbol of AZENTA INC is AZTA and it is listed on the Nasdaq exchange.
AZTA stock is listed on the Nasdaq exchange.
12 analysts have analysed AZTA and the average price target is 32.03 USD. This implies a price increase of 2.79% is expected in the next year compared to the current price of 31.16. Check the AZENTA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AZENTA INC (AZTA) has a market capitalization of 1.43B USD. This makes AZTA a Small Cap stock.
AZENTA INC (AZTA) currently has 3000 employees.
AZENTA INC (AZTA) has a support level at 28.43 and a resistance level at 33.08. Check the full technical report for a detailed analysis of AZTA support and resistance levels.
The Revenue of AZENTA INC (AZTA) is expected to decline by -8.96% in the next year. Check the estimates tab for more information on the AZTA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AZTA does not pay a dividend.
AZENTA INC (AZTA) will report earnings on 2025-07-31, after the market close.
The PE ratio for AZENTA INC (AZTA) is 66.3. This is based on the reported non-GAAP earnings per share of 0.47 and the current share price of 31.16 USD. Check the full fundamental report for a full analysis of the valuation metrics for AZTA.
The outstanding short interest for AZENTA INC (AZTA) is 10.91% of its float. Check the ownership tab for more information on the AZTA short interest.
ChartMill assigns a technical rating of 3 / 10 to AZTA. When comparing the yearly performance of all stocks, AZTA is a bad performer in the overall market: 84.37% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to AZTA. While AZTA has a great health rating, there are worries on its profitability.
Over the last trailing twelve months AZTA reported a non-GAAP Earnings per Share(EPS) of 0.47. The EPS increased by 42.42% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -3.2% | ||
ROE | -3.84% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 52% to AZTA. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 9.63% and a revenue growth -8.96% for AZTA